Transaction

Clearwater advises Westfield Medical on its sale to Sterimed Group

Transaction

Maven Capital Partners on its sale of Westfield Medical to Sterimed Group

Sell-side

Undisclosed

Role

Adviser to Maven Capital Partners on the sale of Westfield Medical to Sterimed Group

Sector

Healthcare
Industrial & Chemicals

Region

UK

Clearwater has advised Maven Capital Partners and management on the sale of Westfield Medical, a leading supplier of medical sterilisation packaging solutions, to Sterimed Group.

Established for over 45 years, Westfield Medical has developed a strong market presence in the UK and internationally with a complete product offering for hospitals and medical device manufacturers. The company supplies sterilisation pouches, reels, bags, wraps and tray liners, manufactured at its facility near Bristol.

In addition to developing long standing relationship with its customers, Westfield Medical has invested in developing and launching innovative products, including Humipak®, a unique moisture retention pouch for post-operative instrument handling, helping increase sterilisation efficiency and reduce the risk of hospital acquired infections.

Westfield Medical has a long-standing reputation for excellence and a strong brand in the sterilisation packaging marketplace, serving the UK NHS and its global customer base with high quality products.

image 116

I am thrilled to welcome Westfield Medical in the Sterimed Group: we have been impressed by the work executed by James Vero and his teams over the last years, and we are convinced that the combination of our two companies will create strong value for our customers and for patients safety. This is going to reinforce Sterimed presence in the UK and in a lot of international markets, whilst allowing Westfield Medical to even better leverage its product range and brands for an accelerated development.

Thibaut Hyvernat, President and CEO of Sterimed
image 116

The sale of Westfield represents a good return for our investors. The management team have been instrumental in successfully delivering the organic growth plan in recent years and the business has performed strongly. The sale to the Sterimed Group is a great strategic fit for Westfield with significant opportunities for the two businesses to explore. It has been a pleasure to work with the Westfield management team and we wish them well as the company embarks on the next stage of its growth.

Tom Purkis, Partner at Maven

We have enjoyed supporting the shareholders and management of Westfield Medical in delivering this transaction. Sterimed feels a very natural home for Westfield and its team, and we are confident the combination will unlock significant benefits for both businesses in future. More broadly, this deal further illustrates the global interest we are seeing in innovative, specialist packaging businesses based here in the UK.

Michael Loudon, Partner, Clearwater

Westfield Medical supplies sterilisation barrier packaging (SBP) to the NHS and medical device manufacturers. The SBP market is set to grow as elective surgery numbers picks up post pandemic. We see promising product development, sales cross fertilisation and procurement synergies under Sterimed’s stewardship. We wish both companies all the success for the future.

Will Arnold, Director, Clearwater

Advisers

Transactions